Form D · Pharmaceuticals

Strongbridge Biopharma plc

Trevose, PA · CIK 0001634432

Offering snapshot reported Dec 30, 2016 · SEC filing

Reported sold
$35M
Offering amount: $35M
Investors reported
23
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 22, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 30, 2016Initial$35,000,000No comparison23SEC filing
Sep 14, 2015Initial$126,000,000No comparison46SEC filing
Jul 17, 2015Initial$33,224,981No comparison25SEC filing
Feb 25, 2015Initial$26,397,676No comparison5SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$2.1M
Finders' fees
$0
Form D file number
021-277441

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Stifel, Nicolaus & Company, Incorporated793
Arctic Securities LLC174423

Source: Form D, filed Dec 30, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fredric Cohen Executive
A. Brian Davis Executive
Brian Davis Executive
A. Brian Davis Executive
Ernest Eichenberg Iii Director
John H. Johnson Director
Espen Tidemann Jorgensen Director
Richard Kollender Director
Garheng Kong Director
Alexander Lindstrom Executive
Stephen Long Executive
Steve Long Executive
Robert Lutz Executive
Joseph M. Mahady Director
Matthew Pauls Director, Executive
H. Joseph Reiser Director
Jeffrey W. Sherman Director
Eigil Stray Spetalen Director
Marten Steen Director
Hilde H. Steineger Director
Ruth Thieroff Ekerdt Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
900 Northbrook Drive Suite 200
Trevose, PA, 19053